Michael Andäng

Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden.

Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden.

Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden.

Liv Diagnostics AB engages in the development of prototype for the diagnosis of breast cancer cells. Its products include CellRACE, which a diagnostic test that initially used for diagnosis and follow-up of breast cancer. The company was founded by Johan Bjurquist, Patrik Sundh, Michael Andäng, and Hanne Evenbratt in 2016 and is headquartered in Moelndal, Sweden.